These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 35574326)

  • 1. Targeting Mitochondrial Oxidative Phosphorylation Eradicates Acute Myeloid Leukemic Stem Cells.
    Peng M; Huang Y; Zhang L; Zhao X; Hou Y
    Front Oncol; 2022; 12():899502. PubMed ID: 35574326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting mitochondrial respiration for the treatment of acute myeloid leukemia.
    Carter JL; Hege K; Kalpage HA; Edwards H; Hüttemann M; Taub JW; Ge Y
    Biochem Pharmacol; 2020 Dec; 182():114253. PubMed ID: 33011159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine.
    Buettner R; Nguyen LXT; Morales C; Chen MH; Wu X; Chen LS; Hoang DH; Hernandez Vargas S; Pullarkat V; Gandhi V; Marcucci G; Rosen ST
    J Hematol Oncol; 2021 Apr; 14(1):70. PubMed ID: 33902674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold.
    Griessinger E; Pereira-Martins D; Nebout M; Bosc C; Saland E; Boet E; Sahal A; Chiche J; Debayle D; Fleuriot L; Pruis M; De Mas V; Vergez F; Récher C; Huls G; Sarry JE; Schuringa JJ; Peyron JF
    Cancer Res; 2023 Aug; 83(15):2461-2470. PubMed ID: 37272750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific Depletion of Leukemic Stem Cells: Can MicroRNAs Make the Difference?
    Martiáñez Canales T; de Leeuw DC; Vermue E; Ossenkoppele GJ; Smit L
    Cancers (Basel); 2017 Jun; 9(7):. PubMed ID: 28665351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic OXPHOS limitations underlie cellular bioenergetics in leukemia.
    Nelson MA; McLaughlin KL; Hagen JT; Coalson HS; Schmidt C; Kassai M; Kew KA; McClung JM; Neufer PD; Brophy P; Vohra NA; Liles D; Cabot MC; Fisher-Wellman KH
    Elife; 2021 Jun; 10():. PubMed ID: 34132194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism.
    Farge T; Saland E; de Toni F; Aroua N; Hosseini M; Perry R; Bosc C; Sugita M; Stuani L; Fraisse M; Scotland S; Larrue C; Boutzen H; Féliu V; Nicolau-Travers ML; Cassant-Sourdy S; Broin N; David M; Serhan N; Sarry A; Tavitian S; Kaoma T; Vallar L; Iacovoni J; Linares LK; Montersino C; Castellano R; Griessinger E; Collette Y; Duchamp O; Barreira Y; Hirsch P; Palama T; Gales L; Delhommeau F; Garmy-Susini BH; Portais JC; Vergez F; Selak M; Danet-Desnoyers G; Carroll M; Récher C; Sarry JE
    Cancer Discov; 2017 Jul; 7(7):716-735. PubMed ID: 28416471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of leukemic stem cells in acute leukemia and potential targeted therapies for their specific eradication.
    Hansen Q; Bachas C; Smit L; Cloos J
    Cancer Drug Resist; 2022; 5(2):344-367. PubMed ID: 35800375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of mitochondrial oxidative phosphorylation by chidamide eradicates leukemic cells in AML.
    Wang JD; Xu JQ; Long ZJ; Weng JY
    Clin Transl Oncol; 2023 Jun; 25(6):1805-1820. PubMed ID: 36899123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Metabolic Dependencies Fueling the TCA Cycle to Circumvent Therapy Resistance in Acute Myeloid Leukemia.
    Boët E; Sarry JE
    Cancer Res; 2024 Apr; 84(7):950-952. PubMed ID: 38558131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia.
    Pollyea DA; Stevens BM; Jones CL; Winters A; Pei S; Minhajuddin M; D'Alessandro A; Culp-Hill R; Riemondy KA; Gillen AE; Hesselberth JR; Abbott D; Schatz D; Gutman JA; Purev E; Smith C; Jordan CT
    Nat Med; 2018 Dec; 24(12):1859-1866. PubMed ID: 30420752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism.
    Polak A; Bialopiotrowicz E; Krzymieniewska B; Wozniak J; Stojak M; Cybulska M; Kaniuga E; Mikula M; Jablonska E; Gorniak P; Noyszewska-Kania M; Szydlowski M; Piechna K; Piwocka K; Bugajski L; Lech-Maranda E; Barankiewicz J; Kolkowska-Lesniak A; Patkowska E; Glodkowska-Mrowka E; Baran N; Juszczynski P
    Cell Death Dis; 2020 Nov; 11(11):956. PubMed ID: 33159047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
    Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
    Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation.
    Amaya ML; Inguva A; Pei S; Jones C; Krug A; Ye H; Minhajuddin M; Winters A; Furtek SL; Gamboni F; Stevens B; D'Alessandro A; Pollyea DA; Reigan P; Jordan CT
    Blood; 2022 Jan; 139(4):584-596. PubMed ID: 34525179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative resistance of leukemic stem cells and oxidative damage to hematopoietic stem cells under pro-oxidative therapy.
    Chen Y; Liang Y; Luo X; Hu Q
    Cell Death Dis; 2020 Apr; 11(4):291. PubMed ID: 32341354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities.
    Marchand T; Pinho S
    Front Immunol; 2021; 12():775128. PubMed ID: 34721441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity.
    Rodriguez-Zabala M; Ramakrishnan R; Reinbach K; Ghosh S; Oburoglu L; Falqués-Costa A; Bellamkonda K; Ehinger M; Peña-Martínez P; Puente-Moncada N; Lilljebjörn H; Cammenga J; Pronk CJ; Lazarevic V; Fioretos T; Hagström-Andersson AK; Woods NB; Järås M
    Blood Adv; 2023 Sep; 7(18):5382-5395. PubMed ID: 37505194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress in the leukemic stem cell study and a novel therapeutic approach targeting leukemic stem cells].
    Kikushige Y; Miyamoto T; Akashi K
    Rinsho Ketsueki; 2017; 58(10):1838-1843. PubMed ID: 28978822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid Leukemia.
    Kikushige Y; Miyamoto T
    Oncology; 2015; 89 Suppl 1():28-32. PubMed ID: 26551150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential redox-regulation and mitochondrial dynamics in normal and leukemic hematopoietic stem cells: A potential window for leukemia therapy.
    Mattes K; Vellenga E; Schepers H
    Crit Rev Oncol Hematol; 2019 Dec; 144():102814. PubMed ID: 31593878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.